<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Rheumatology</title>
            <link>https://medicalxpress.com/rheumatology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Rheumatology</description>

                            <item>
                    <title>Blocking receptor signals can help treat fibrosis</title>
                    <description>In an investigator-initiated trial, researchers have shown that inhibiting the cytokines IL-4 and IL-13 can prevent fibrosis in the skin disease localized scleroderma. These findings could pave the way for the prevention and treatment of other fibrotic conditions. The study &quot;Interleukin 4 receptor-α blockade in localised scleroderma: a phase II proof-of-concept study&quot; was published in the journal Annals of the Rheumatic Diseases.</description>
                    <link>https://medicalxpress.com/news/2026-11-blocking-receptor-fibrosis.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 10:00:01 EST</pubDate>
                    <guid isPermaLink="false">news714304182</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/working-model-for-inte.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New evidence questions benefits of turmeric for knee arthritis</title>
                    <description>A new Cochrane review has found that turmeric supplements may provide little or no clinically important pain relief for people with knee osteoarthritis, challenging conclusions from earlier research that suggested a benefit. The work appears in the Cochrane Database of Systematic Reviews.</description>
                    <link>https://medicalxpress.com/news/2026-11-evidence-benefits-turmeric-knee-arthritis.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 20:00:05 EST</pubDate>
                    <guid isPermaLink="false">news714204284</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/turmeric.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blood thinner could offer a new way to treat osteoarthritis</title>
                    <description>Osteoarthritis is the most common form of joint disease, a condition that causes joints to become painful and stiff. It can happen to any joint when the cartilage cushioning the ends of bones breaks down or wears away. Currently, there are no approved drugs to slow or stop the underlying disease. But there is a promising development from an unexpected quarter—a blood thinner.</description>
                    <link>https://medicalxpress.com/news/2026-11-blood-thinner-osteoarthritis.html</link>
                    <category></category>
                    <pubDate>Thu, 12 Nov 2026 12:00:13 EST</pubDate>
                    <guid isPermaLink="false">news713704879</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/blood-thinner-could-of.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials</title>
                    <description>For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those taking the highest dose of retatrutide, a new experimental weight-loss injectable drug, lost about one-quarter of their body weight on average.</description>
                    <link>https://medicalxpress.com/news/2026-11-experimental-weight-loss-drug-eases.html</link>
                    <category></category>
                    <pubDate>Sun, 08 Nov 2026 11:30:01 EST</pubDate>
                    <guid isPermaLink="false">news713177942</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/painful-knee.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Targeting hormone receptors reduces lupus-related kidney damage in mice</title>
                    <description>Researchers at the University of California, Riverside, and City of Hope have identified a new strategy for treating systemic lupus erythematosus (SLE), or lupus, an autoimmune disease in which the immune system attacks healthy tissues. By targeting an imbalance in receptors for the hormone prolactin in disease-causing immune cells, the team reduced inflammatory molecules and harmful immune cells while preserving their normal counterparts.</description>
                    <link>https://medicalxpress.com/news/2026-11-hormone-receptors-lupus-kidney-mice.html</link>
                    <category></category>
                    <pubDate>Mon, 02 Nov 2026 15:40:06 EST</pubDate>
                    <guid isPermaLink="false">news712846797</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-strategy-identifie-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Mutated immune cells raise red flags in lupus</title>
                    <description>Scientists at La Jolla Institute for Immunology (LJI) and the University of Washington (UW) have discovered that patients with lupus have unusual mutations that may turn their bodies into battlegrounds.</description>
                    <link>https://medicalxpress.com/news/2026-10-mutated-immune-cells-red-flags.html</link>
                    <category></category>
                    <pubDate>Wed, 28 Oct 2026 18:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news712424904</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/cells-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How psychological stress can trigger arthritis flares via an inflammatory pathway</title>
                    <description>Psychological stress has long been associated with worsening symptoms in rheumatoid arthritis (RA). However, the underlying mechanism connecting psychological stress to the occurrence of joint inflammation has remained poorly understood. In particular, how psychological stress can trigger inflammation in joints that were previously affected, even after the disease has gone into remission, remains an important unanswered question.</description>
                    <link>https://medicalxpress.com/news/2026-10-psychological-stress-trigger-arthritis-flares.html</link>
                    <category></category>
                    <pubDate>Fri, 16 Oct 2026 14:00:10 EDT</pubDate>
                    <guid isPermaLink="false">news711300001</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-psychological-stre.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Can we take the STING out of bone loss? Pathway presents potential treatment target for skeletal aging</title>
                    <description>As we age, our bones become weak and brittle, a process called osteoporosis. This bone loss is caused by changes in the cells within the bone marrow microenvironment, such as elevated fat and inflammation-promoting immune cells. One molecular driver of inflammation is the STING signaling pathway, though the role of this pathway in aging bones has until now been unclear.</description>
                    <link>https://medicalxpress.com/news/2026-10-bone-loss-pathway-potential-treatment.html</link>
                    <category></category>
                    <pubDate>Thu, 15 Oct 2026 03:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news711201542</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/osteoporosis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Simple, noninvasive technique can assess collagen in the skin of scleroderma patients</title>
                    <description>Scleroderma (systemic sclerosis) is a rare, chronic autoimmune disease that causes the body to produce too much collagen, leading to the hardening and thickening of the skin and internal organs. For more than 50 years, physicians have relied on manually pinching the skin to assess its thickness, a subjective approach that remains central to the diagnosis of systemic sclerosis, assessment of disease extent and progression and monitoring of response to treatment.</description>
                    <link>https://medicalxpress.com/news/2026-10-simple-noninvasive-technique-collagen-skin.html</link>
                    <category></category>
                    <pubDate>Wed, 14 Oct 2026 18:30:34 EDT</pubDate>
                    <guid isPermaLink="false">news711206041</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/inflammed-skin.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Early axial spondyloarthritis diagnosis linked to lower long-term spinal damage</title>
                    <description>Early axial spondyloarthritis (axSpA), with a duration of no more than two years of axial symptoms, is associated with lower long-term spinal structural damage, according to a study published online Sept. 18 in Arthritis &amp; Rheumatology.</description>
                    <link>https://medicalxpress.com/news/2026-10-early-axial-spondyloarthritis-diagnosis-linked.html</link>
                    <category></category>
                    <pubDate>Tue, 13 Oct 2026 15:20:18 EDT</pubDate>
                    <guid isPermaLink="false">news711114027</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/spine.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Females with autoimmune diseases &#039;less likely to be believed&#039; than males and face longer diagnostic delays</title>
                    <description>Females with autoimmune diseases are significantly more likely than males to have their autoimmune disease misdiagnosed as a psychiatric or psychosomatic condition, according to a study of more than 6,600 patients.</description>
                    <link>https://medicalxpress.com/news/2026-10-females-autoimmune-diseases-believed-males.html</link>
                    <category></category>
                    <pubDate>Mon, 12 Oct 2026 18:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news711018601</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/woman-talking-to-docto.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New insights into why the sun makes lupus patients sick</title>
                    <description>Researchers from University of Michigan Health have mapped the cellular path of inflammation after UV exposure in lupus patients.</description>
                    <link>https://medicalxpress.com/news/2026-10-insights-sun-lupus-patients-sick.html</link>
                    <category></category>
                    <pubDate>Tue, 06 Oct 2026 13:00:18 EDT</pubDate>
                    <guid isPermaLink="false">news710509261</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/sun-on-person.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A missing piece in the cell death and inflammation signaling pathway puzzle has been revealed</title>
                    <description>An international research team has discovered a previously unknown mechanism that plays a key role in the signaling pathways involved in programmed cell death. The team identified the protein HERC4 as an essential component of both TNF-induced necroptosis and apoptosis pathways—two processes that play a crucial role in maintaining cellular balance and triggering inflammatory responses.</description>
                    <link>https://medicalxpress.com/news/2026-09-piece-cell-death-inflammation-pathway.html</link>
                    <category></category>
                    <pubDate>Mon, 28 Sep 2026 15:40:16 EDT</pubDate>
                    <guid isPermaLink="false">news709826379</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/one-of-the-final-piece.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
